Study finds elevated risk of rare blood cancers after chemotherapy for most solid tumors

(NIH/National Cancer Institute) Findings from a new study by researchers at the National Cancer Institute (NCI) show that patients treated with chemotherapy for most solid tumors during 2000-2014 experienced an increased risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML). The study was published December 20, 2018, in JAMA Oncology. NCI is part of the National Institutes of Health.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news